EMEA (Europe, Middle East and Africa) Onychomycosis (Tinea Unguium) Drug Market Report 2017

January 2018 | 109 pages | ID: EC11694BED0EN
QYResearch

Abstracts

In this report, the EMEA Onychomycosis (Tinea Unguium) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Onychomycosis (Tinea Unguium) Drug for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Onychomycosis (Tinea Unguium) Drug market competition by top manufacturers/players, with Onychomycosis (Tinea Unguium) Drug sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Johnson & Johnson
• GSK
• Novartis
• Pfizer
• Valeant Pharma
• Kaken Pharmaceutical
• Galderma
• Xiuzheng Pharmaceutical
• Letai
• Qilu Pharmaceutical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Oral Type
• External Use Type

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Age under 18
• Age 18-50
• Age above 50

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Onychomycosis (Tinea Unguium) Drug Market Report 2017

1 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG OVERVIEW

1.1 Product Overview and Scope of Onychomycosis (Tinea Unguium) Drug
1.2 Classification of Onychomycosis (Tinea Unguium) Drug
  1.2.1 EMEA Onychomycosis (Tinea Unguium) Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Onychomycosis (Tinea Unguium) Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Oral Type
  1.2.4 External Use Type
1.3 EMEA Onychomycosis (Tinea Unguium) Drug Market by Application/End Users
  1.3.1 EMEA Onychomycosis (Tinea Unguium) Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Age under
  1.3.3 Age 18-50
  1.3.4 Age above
1.4 EMEA Onychomycosis (Tinea Unguium) Drug Market by Region
  1.4.1 EMEA Onychomycosis (Tinea Unguium) Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Onychomycosis (Tinea Unguium) Drug (2012-2022)
  1.5.1 EMEA Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2012-2022)

2 EMEA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Onychomycosis (Tinea Unguium) Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Onychomycosis (Tinea Unguium) Drug Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Onychomycosis (Tinea Unguium) Drug Sale Price by Players (2012-2017)
2.2 EMEA Onychomycosis (Tinea Unguium) Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Onychomycosis (Tinea Unguium) Drug Sale Price by Type (2012-2017)
2.3 EMEA Onychomycosis (Tinea Unguium) Drug (Volume) by Application
2.4 EMEA Onychomycosis (Tinea Unguium) Drug (Volume and Value) by Region
  2.4.1 EMEA Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Onychomycosis (Tinea Unguium) Drug Sales Price by Region (2012-2017)

3 EUROPE ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Onychomycosis (Tinea Unguium) Drug Sales and Value (2012-2017)
  3.1.1 Europe Onychomycosis (Tinea Unguium) Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2012-2017)
3.2 Europe Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type
3.3 Europe Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application
3.4 Europe Onychomycosis (Tinea Unguium) Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Onychomycosis (Tinea Unguium) Drug Sales Volume by Countries (2012-2017)
  3.4.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2012-2017)
  3.4.3 Germany Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)
  3.4.4 France Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)
  3.4.5 UK Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)
  3.4.6 Russia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)
  3.4.7 Italy Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Onychomycosis (Tinea Unguium) Drug Sales and Value (2012-2017)
  4.1.1 Middle East Onychomycosis (Tinea Unguium) Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type
4.3 Middle East Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application
4.4 Middle East Onychomycosis (Tinea Unguium) Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Onychomycosis (Tinea Unguium) Drug Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)
  4.4.4 Israel Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)
  4.4.5 UAE Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)
  4.4.6 Iran Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)

5 AFRICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Onychomycosis (Tinea Unguium) Drug Sales and Value (2012-2017)
  5.1.1 Africa Onychomycosis (Tinea Unguium) Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2012-2017)
5.2 Africa Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type
5.3 Africa Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application
5.4 Africa Onychomycosis (Tinea Unguium) Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Onychomycosis (Tinea Unguium) Drug Sales Volume by Countries (2012-2017)
  5.4.2 Africa Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2012-2017)
  5.4.3 South Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2017)

6 EMEA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Johnson & Johnson
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Onychomycosis (Tinea Unguium) Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GSK
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Onychomycosis (Tinea Unguium) Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Onychomycosis (Tinea Unguium) Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Onychomycosis (Tinea Unguium) Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Valeant Pharma
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Onychomycosis (Tinea Unguium) Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Kaken Pharmaceutical
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Onychomycosis (Tinea Unguium) Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Galderma
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Onychomycosis (Tinea Unguium) Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Xiuzheng Pharmaceutical
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Onychomycosis (Tinea Unguium) Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Letai
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Onychomycosis (Tinea Unguium) Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Qilu Pharmaceutical
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Onychomycosis (Tinea Unguium) Drug Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MANUFACTURING COST ANALYSIS

7.1 Onychomycosis (Tinea Unguium) Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET FORECAST (2017-2022)

11.1 EMEA Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Onychomycosis (Tinea Unguium) Drug Price and Trend Forecast (2017-2022)
11.2 EMEA Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2017-2022)
11.7 EMEA Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Onychomycosis (Tinea Unguium) Drug
Figure EMEA Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Type Product Picture
Figure External Use Type Product Picture
Figure EMEA Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Application in 2016
Figure Age under 18 Examples
Table Key Downstream Customer in Age under
Figure Age 18-50 Examples
Table Key Downstream Customer in Age 18-50
Figure Age above 50 Examples
Table Key Downstream Customer in Age above
Figure EMEA Onychomycosis (Tinea Unguium) Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Onychomycosis (Tinea Unguium) Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Onychomycosis (Tinea Unguium) Drug Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Onychomycosis (Tinea Unguium) Drug Sales Share by Players (2012-2017)
Figure 2016 Onychomycosis (Tinea Unguium) Drug Sales Share by Players
Figure 2017 Onychomycosis (Tinea Unguium) Drug Sales Share by Players
Figure EMEA Onychomycosis (Tinea Unguium) Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA Onychomycosis (Tinea Unguium) Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA Onychomycosis (Tinea Unguium) Drug Revenue Share by Players
Table 2017 EMEA Onychomycosis (Tinea Unguium) Drug Revenue Share by Players
Table EMEA Onychomycosis (Tinea Unguium) Drug Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Type (2012-2017)
Figure EMEA Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2012-2017)
Table EMEA Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Onychomycosis (Tinea Unguium) Drug by Type in 2016
Table EMEA Onychomycosis (Tinea Unguium) Drug Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Onychomycosis (Tinea Unguium) Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Application (2012-2017)
Figure EMEA Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2016
Table EMEA Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Onychomycosis (Tinea Unguium) Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Region (2012-2017)
Figure EMEA Onychomycosis (Tinea Unguium) Drug Sales Market Share in 2016
Table EMEA Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Onychomycosis (Tinea Unguium) Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Onychomycosis (Tinea Unguium) Drug by Region (2012-2017)
Figure EMEA Onychomycosis (Tinea Unguium) Drug Revenue Market Share Regions in 2016
Table EMEA Onychomycosis (Tinea Unguium) Drug Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2012-2017)
Table Europe Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Type (2012-2017)
Table Europe Onychomycosis (Tinea Unguium) Drug Market Share by Type (2012-2017)
Figure Europe Onychomycosis (Tinea Unguium) Drug Market Share by Type in 2016
Table Europe Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Application (2012-2017)
Table Europe Onychomycosis (Tinea Unguium) Drug Market Share by Application (2012-2017)
Figure Europe Onychomycosis (Tinea Unguium) Drug Market Share by Application in 2016
Table Europe Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Countries (2012-2017)
Table Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2012-2017)
Figure Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2012-2017)
Figure Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries in 2016
Table Europe Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2016
Figure Germany Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure France Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure UK Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Type (2012-2017)
Table Middle East Onychomycosis (Tinea Unguium) Drug Market Share by Type (2012-2017)
Figure Middle East Onychomycosis (Tinea Unguium) Drug Market Share by Type (2012-2017)
Table Middle East Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Applications (2012-2017)
Table Middle East Onychomycosis (Tinea Unguium) Drug Market Share by Applications (2012-2017)
Figure Middle East Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2016
Table Middle East Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Countries in 2016
Table Middle East Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Type (2012-2017)
Table Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2012-2017)
Figure Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2012-2017)
Figure Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2016
Table Africa Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Application (2012-2017)
Table Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2012-2017)
Figure Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2012-2017)
Table Africa Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Countries (2012-2017)
Table Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2012-2017)
Figure Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2012-2017)
Figure Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries in 2016
Table Africa Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2016
Figure South Africa Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Revenue Market Share in EMEA (2012-2017)
Table GSK Onychomycosis (Tinea Unguium) Drug Basic Information List
Table GSK Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GSK Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure GSK Onychomycosis (Tinea Unguium) Drug Sales Market Share in EMEA (2012-2017)
Figure GSK Onychomycosis (Tinea Unguium) Drug Revenue Market Share in EMEA (2012-2017)
Table Novartis Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Novartis Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Novartis Onychomycosis (Tinea Unguium) Drug Sales Market Share in EMEA (2012-2017)
Figure Novartis Onychomycosis (Tinea Unguium) Drug Revenue Market Share in EMEA (2012-2017)
Table Pfizer Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Pfizer Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Onychomycosis (Tinea Unguium) Drug Sales Market Share in EMEA (2012-2017)
Figure Pfizer Onychomycosis (Tinea Unguium) Drug Revenue Market Share in EMEA (2012-2017)
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales Market Share in EMEA (2012-2017)
Figure Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue Market Share in EMEA (2012-2017)
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales Market Share in EMEA (2012-2017)
Figure Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue Market Share in EMEA (2012-2017)
Table Galderma Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Galderma Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Galderma Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Galderma Onychomycosis (Tinea Unguium) Drug Sales Market Share in EMEA (2012-2017)
Figure Galderma Onychomycosis (Tinea Unguium) Drug Revenue Market Share in EMEA (2012-2017)
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales Market Share in EMEA (2012-2017)
Figure Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue Market Share in EMEA (2012-2017)
Table Letai Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Letai Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Letai Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Letai Onychomycosis (Tinea Unguium) Drug Sales Market Share in EMEA (2012-2017)
Figure Letai Onychomycosis (Tinea Unguium) Drug Revenue Market Share in EMEA (2012-2017)
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales Market Share in EMEA (2012-2017)
Figure Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Onychomycosis (Tinea Unguium) Drug
Figure Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug
Figure Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
Table Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Manufacturers in 2016
Table Major Buyers of Onychomycosis (Tinea Unguium) Drug
Table Distributors/Traders List
Figure EMEA Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Onychomycosis (Tinea Unguium) Drug Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Onychomycosis (Tinea Unguium) Drug Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe Onychomycosis (Tinea Unguium) Drug Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Onychomycosis (Tinea Unguium) Drug Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Onychomycosis (Tinea Unguium) Drug Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Onychomycosis (Tinea Unguium) Drug Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA Onychomycosis (Tinea Unguium) Drug Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources